To view this email as a web page, click here.
April 18, 2019
 
Febuxostat is Out for Gout Treatment
In February, the Food and Drug Administration issued a boxed warning for the gout treatment febuxostat (Uloric, Takeda) citing a risk for cardiovascular disease. It was approved in 2009 for adult patients with gout. Learn more about this and the 2012 treatment guidelines for gout in this slideshow.
Read more
 
Q&A: Treatments for Gout
Robert Terkeltaub M.D., the rheumatology section chief of the VA Medical Center in San Diego and the corresponding author of the first-ever treatment guidelines for gout by the American College of Rheumatology, recently spoke with Rheumatology Network about updates in gout treatment.
Read more
 
More from Rheumatology Network on Gout
 
Fatty Acids In Food Superior To Supplements
When it comes to reducing the risk of gout flares, dietary sources of omega-3 polyunsaturated fatty acids may be superior to supplements, shows a new study.
Read more
 
Gout: Updates From ACR 2018
Two recent studies examine early characteristics and urate-associated mortality in gout.
Read more
 
Gout Patients Prefer Drugs (And Cherry Extract)
Survey shows that gout patients prefer prescription medicine and natural remedies for gout. Researchers urge adopting a patient-centric approach to care.
Read more